The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Objectives of this study were to investigate the effects of prolonged-release melatonin 2 mg (PRM) on sleep and subsequent daytime psychomotor performance in patients aged > or =55 years with primary insomnia, as defined by fourth revision of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association. Patients (N = 40) were treated nightly single-blind with placebo (2 weeks), randomized double-blind to PRM or placebo (3 weeks) followed by withdrawal period (3 weeks). Sleep was assessed by polysomnography, all-night sleep electroencephalography spectral analysis and questionnaires. Psychomotor performance was assessed by the Leeds Psychomotor Test battery. By the end of the double-blind treatment, the PRM group had significantly shorter sleep onset latency (9 min; P = 0.02) compared with the placebo group and scored significantly better in the Critical Flicker Fusion Test (P = 0.008) without negatively affecting sleep structure and architecture. Half of the patients reported substantial improvement in sleep quality at home with PRM compared with 15% with placebo (P = 0.018). No rebound effects were observed during withdrawal. In conclusion, nightly treatment with PRM effectively induced sleep and improved perceived quality of sleep in patients with primary insomnia aged > or =55 years. Daytime psychomotor performance was not impaired and was consistently better with PRM compared with placebo. PRM was well tolerated with no evidence of rebound effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brzezinski, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360306 · Cited by 1,549
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161 · cited 2×
“For some of these agents, concerns have also been raised about the possibility of psychomotor and cognitive impairments, development of dependence or rebound insomnia, so that their use is discouraged, particularly in elderly patients (Glass et al., 2005).”
BackgroundEffects of exogenous melatonin on sleep: a meta-analysis
Brzezinski, A., Vangel, M. G., Wurtman, R. J., Norrie, G., Zhdanova, I., Ben-Shushan, A., & Ford, I. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.06.004 · Cited by 541 · cited 1×
“Unlike BZDs and BZD-like drugs, melatonin is described in most studies as producing no effects on stage 2 and stage 3–4 sleep (Cramer et al., 1974; James et al., 1990; Zhdanova et al., 2001; Brzezinski et al., 2005; Gorfine et al., 2007).”
BackgroundThe Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-Analysis of RCTs
Buscemi, N., Vandermeer, B., Friesen, C., Bialy, L., Tubman, M., Ospina, M., Klassen, T. P., & Witmans, M. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0251-z · Cited by 448
Functional link between distal vasodilation and sleep-onset latency?
Kräuchi, K., Cajochen, C., Werth, E., & Wirz-Justice, A. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.3.r741 · Cited by 356 · cited 2×
“temperature, blood pressure and hormones) (Brzezinski, 1997; Shochat et al., 1998; Krauchi et al., 2000).”
BackgroundMelatonin treatment for age-related insomnia
Zhdanova, I. V., Wurtman, R. J., Regan, M. M., Taylor, J. A., Shi, J. P., & Leclair, O. U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7901 · Cited by 308
Practice Parameters for Using Polysomnography to Evaluate Insomnia: An Update
Littner, M., Hirshkowitz, M., Kramer, M., Kapen, S., Anderson, W. M., Bailey, D., Berry, R. B., Davila, D., Johnson, S., Kushida, C., et al. (2003) · Sleep · doi:10.1093/sleep/26.6.754 · Cited by 306 · cited 1×
“In many patients who suffer immensely from the poor quality of their sleep, sleep quantity is within the normal limits (Costa e Silva et al., 1996; Riedel and Lichstein, 1998; Bastien et al., 2003b; Littner et al., 2003).”
BackgroundAccuracy of sleep perceptions among insomnia sufferers and normal sleepers
Means, M. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00057-1 · Cited by 217 · cited 1×
“This is not surprising, as it is now well recognized in the sleep medicine field that poor QOS (or nonrestorative sleep) does not have a reliable PSG correlate (DSM-IV, 1994; Baker et al., 1999; Means et al., 2003; Bastien et al., 2003a; Harvey et al., 2008).”
BackgroundBaker, F. C., Maloney, S., & Driver, H. S. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00017-3 · Cited by 209 · cited 1×
“This is not surprising, as it is now well recognized in the sleep medicine field that poor QOS (or nonrestorative sleep) does not have a reliable PSG correlate (DSM-IV, 1994; Baker et al., 1999; Means et al., 2003; Bastien et al., 2003a; Harvey et al., 2008).”
BackgroundEdinger, J. D., Means, M. K., Carney, C. E., & Krystal, A. D. (2008) · Sleep · doi:10.1093/sleep/31.5.599 · Cited by 168
Gorfine, T., Yeshurun, Y., & Zisapel, N. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00482.x · Cited by 42
Self-citation
Cited by
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Ferracioli-Oda, E., Qawasmi, A., & Bloch, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063773 · Cited by 483
Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders
Auld, F., Maschauer, E. L., Morrison, I., Skene, D. J., & Riha, R. L. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.06.005 · Cited by 393
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Atkin, T., Comai, S., & Gobbi, G. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014381 · Cited by 391
Foley, H. M., & Steel, A. E. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.11.003 · Cited by 144
Metadata
- Authors
- Luthringer, R., Muzet, M., Zisapel, N., & Staner, L.
- Venue
- International Clinical Psychopharmacology
- Published
- 2009-09
- Volume
- 24
- Issue
- 5
- Pages
- 239-249
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2039647336
- Cited by
- 136
- References
- 11
- FWCI
- 11.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.